ProfileGDS4814 / ILMN_1708841
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 95% 95% 95% 95% 95% 95% 95% 95% 95% 95% 95% 95% 95% 95% 95% 95% 95% 95% 95% 95% 95% 95% 96% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)833.49695
GSM780708Untreated after 4 days (C2_1)872.55895
GSM780709Untreated after 4 days (C3_1)836.90795
GSM780719Untreated after 4 days (C1_2)846.63195
GSM780720Untreated after 4 days (C2_2)916.22795
GSM780721Untreated after 4 days (C3_2)857.1495
GSM780710Trastuzumab treated after 4 days (T1_1)914.60195
GSM780711Trastuzumab treated after 4 days (T2_1)875.74795
GSM780712Trastuzumab treated after 4 days (T3_1)827.5595
GSM780722Trastuzumab treated after 4 days (T1_2)850.41495
GSM780723Trastuzumab treated after 4 days (T2_2)826.8395
GSM780724Trastuzumab treated after 4 days (T3_2)948.7295
GSM780713Pertuzumab treated after 4 days (P1_1)938.96395
GSM780714Pertuzumab treated after 4 days (P2_1)840.19295
GSM780715Pertuzumab treated after 4 days (P3_1)928.70995
GSM780725Pertuzumab treated after 4 days (P1_2)875.74795
GSM780726Pertuzumab treated after 4 days (P2_2)849.05895
GSM780727Pertuzumab treated after 4 days (P3_2)878.31595
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)934.90495
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)973.31995
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)873.14295
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)931.41295
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)1063.9796